Kepos Capital LP 13D and 13G filings for Virpax Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-26 4:05 pm Sale |
2022-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX |
Kepos Capital LP | 0 0.000% |
-3,000 (Position Closed) |
Filing |
| 2022-02-04 08:18 am Purchase |
2021-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX |
Kepos Capital LP | 3,000 6.400% |
3,000 (New Position) |
Filing |